1.DC-CIK combined with surgical therapy for primary liver cancer
Hongmu LONG ; Zhongping XU ; Xianfeng CHEN ; Jiangchao ZENG ; Gang LIU
International Journal of Surgery 2017;44(4):255-259,封4
Objective To evaluate the clinical efficacy of dendritic cells-cytokine induced killer cells combined with surgical treatment for primary liver cancer.Methods Totally 78 patients with primary liver cancer were randomly divided into experiment group (n =30) and control group (n =48).The patients in experiment group received hcpatectomy combined with dendritic cells-cytokine induced killer cell treatment while those in control group were given hepatectomy treatment.The median time to recurrence,progression-free survival,survival and quality of life were evaluated.Observed side effects of cell therapy in experiment group.Results Experiment group received a total of dendritic cells-cytokine induced killer cell treatment 78,an average of 2.6 times per person.Fever occured in 8 patients who received dendritic cells-cytokine induced killer cell treatment.After one cycle of immune therapy,the KPS score of 20 cases was improved,8 cases were stable and and 2 case was worsen in the experiment group.The KPS score of 10 cases were improved,32 cases were stable and and 6 cases were worsen in the control group,and the difference is statistically significant (P < 0.05).The progression-free survival rates for 1,2 and 3 years in the experiment group were 73.3%,40.0%,23.3% and 68.7%,27.0%,14.5% in the control groups,respectively.The progression-free survival rates in the experiment group were improved compared to the control group and the difference is statistically significant (P < 0.05).The median time of recurrence in the experiment group were (16.9 ± 2.6) months and (13.5 ± 2.9) months in the control group,respectively (P < 0.05).The 1-2-3-years survival rates in the experiment group were 85.0%,50.0%,35.0% and 85.0%,40.0%,23.3% in the control group respectively.There was no statistically significant difference between these two groups (P > 0.05).Conclusions Dendritic cellscytokine induced killer cells combined with surgical treatment on primary liver cancer is safe and effective,it can improve quality of life,and delay the recurrence time after surgery.But not improve long-term survival.
2.Observation of clinical curative effect of operation of splenic salvage on traumatic ruptured spleen using microwave coagulator
Yadong ZHOU ; Hongmu LONG ; Gang LIU ; Jiangchao ZENG ; Xianfeng CHEN ; Jiajian YU ; Zhongping XU
International Journal of Surgery 2014;41(10):666-669
Objective To investigate the clinical effect and safety of spleen-preserving surgery by microwave tissue coagulation (MTC) therapy.Methods Retrospectively analyzed the clinical data of 45 cases undergoing spleen retaining surgery by MTC therapy (observation group) and comparative study was used on another 45 cases experiencing splenectomy (comparative group),clinical effect and complications were compared.All cases were patients from Jan.2010 to Jun.2013.Results All cases were cured.Hospitalization of observation group is obviously shorter than that of comparative group(P =0.007).The rate of complication in observation group(4.44%) is lower than that in comparative group (20.00%),but the time and amount of bleeding in operation of observation group is much more than that of comparative group.Conclusion MTC can effectively guarantee patients safety,shorten hospital stay,and be worthy of popularization.